Imperia Capsaicin Lotion
Natural health product licensed in Canada
- Licence holder
- Imperia Brand Strategies & Solutions Ltd.
- NPN or DIN-HM
- 80062483
- Status
- Active licence
- Licence date
- 6 July 2015
- Revision date
- Not provided
- Form
- Lotion
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| (E)-8-Méthyl-N-vanillyl-6-nonenamide Source : Capsaïcine | 0.25 Pour cent |
Non-medicinal ingredients
Alcool cétéarylique, Cire mise en émulsion, Cétéareth-20, Lanoline, Acide stéarique, Aqua, dl-alpha tocophérol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 2 years | Not specified | Not specified |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Rashes and/or burning discomfort have been known to occur; in which case, discontinue use. Hypersensitivity has been known to occur; in which case, discontinue use. Headache, erythema, redness, and burning discomfort have been known to occur; in which case, discontinue use.
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If symptoms of strain or sprain persist and/or worsen after 7 days or re-occur within a few days, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80062483
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.